Mirae Asset Global ETFs Holdings
CRVS icon

Mirae Asset Global ETFs Holdings’s Corvus Pharmaceuticals CRVS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
40,646
+2,494
+7% +$34.6K ﹤0.01% 1903
2026
Q1 		$548K Buy
38,152
+5,743
+18% +$91.7K ﹤0.01% 1848
2025
Q4 		$248K Buy
32,409
+4,884
+18% +$38.5K ﹤0.01% 2248
2025
Q3 		$203K Sell
27,525
-1,136
-4% -$5.81K ﹤0.01% 2311
2025
Q2 		$115K Buy
+28,661
New +$104K ﹤0.01% 2540

Other funds holding CRVS

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CRVS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Corvus Pharmaceuticals (CRVS) stake by 6.5% in Q2 2026, buying an estimated $34.6K and bringing the position to 40,646 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Mirae Asset Global ETFs Holdings first reported a position in CRVS in Q2 2025 and has held it in 5 quarters since. 173 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 40,646 shares of Corvus Pharmaceuticals worth $603K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,494 Corvus Pharmaceuticals shares in Q2 2026, an estimated $34.6K.
  • Corvus Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1903 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Corvus Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 173 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.